Why Pharma Boards Confuse Scenario Models With Risk Measurements
Why Pharma Boards Confuse Scenario Models With Risk Measurements (And How to Fix It) By [Your Name], Chief Editor, B2B Pulse You’re sitting in a boardroom. The deck shows a tidy waterfall chart: base case, then three scenarios—best, worst, and most likely. The numbers look solid. The CEO leans in. “What’s our actual risk here?” … Read more